1 thereby approaching within a 10-fold incidence of venous thromboembolism (VTE), in well-selected patients. This risk thus demands consideration of whether the procedure should be performed, minimization of risk, and ethical patient consultation and consent.
A variety of technical considerations in the performance of fat grafting to the buttocks have been suggested to limit risk including, but not limited to, access and directionality of injection, size and configuration of the re-injection cannula, 3 rate and pressure of injection, parcel harvest technique and processing, fat graft volume, patient positioning, and ultrasound guidance. However, to date, all autopsies have confirmed fat graft within the gluteal muscle. In other words, there has been no autopsy subsequent to a fat grafting to the buttock mortality with the fat located solely in the subcutaneous space. Furthermore, fat grafting to the buttock mortality has been reported across a variety of specialty backgrounds, education and training, environments of care, and number of procedures performed. Notably, a recent death occurred under the care of a surgeon who had performed more than 2000 of these procedures. Therefore, at present, subcutaneous-only fat grafting to the buttocks appears to be safe whereas intramuscular injection, or combined, may be unsafe pending further elucidation. 4, 5 Furthermore, focused concentration is imperative to avoid inadvertent entry into the muscle.
Second, it is the surgeon's duty to the patient to discuss risks, benefits, and alternatives to treatment. 6 Although mortality customarily appears in consent forms, considering the apparent incidence of fat grafting to the buttock mortality, this demands appropriate attention within the informed consent process. Furthermore, it is incumbent on the surgeon to set balanced expectations for the subcutaneous fat grafting procedure with regard to size gains per stage as it is widely, albeit not universally, held that combined subcutaneous and intramuscular fat grafting yields higher single-stage augmentation gains.
Cosmetic surgery, elective by its very essence, demands overwhelmingly safe and predictable results. The former must not be sacrificed for the benefit of the latter, the pressures of patient expectations, nor lack of awareness of outcomes data. Furthermore, it is possible that individual state legislatures respond in statute to the mounting news reports, as several have done in response to patient safety concerns with liposuction; awareness of such local regulation is mandatory.
Over many years, surgeons routinely injected into muscle 7 believing it to be as safe as any other technique; several experienced surgeons suffered a fatality during the rapid rise in popularity of these procedures while quality research and recommendations failed to keep pace. Likely, anatomic, cadaveric, and patient studies will clarify safe gluteal fat grafting technique. However, at present, thorough and ethical informed consent requires specific consideration of risk of death with gluteal fat injection. Specifically, subcutaneous-only gluteal fat injection in a duly accredited surgical facility, by appropriately credentialed surgeons who are educated, trained, and experienced in this specific procedure, may be considered safe and prudent.
